Livlong, one of India’s fastest-growing healthtech and Insurtech platforms, has reported a revenue of ₹191.6 crore in FY 2024-25, marking a 17.1% year-on-year growth over ₹163.6 crore in FY 2023-24. The platform continues its upward momentum, building on its revenue surge last fiscal year.
The company attributes this growth to its expanding ecosystem through increased penetration of affordable OPD and Health Insurance Products in Tier – II & III markets through various channels like Retail Distribution, Corporate OPD & Wellness, Third Party Partners to name a few.
“FY25 has been a year of penetration and consolidation. Crossing ₹191.6 crore in revenue reaffirms our market leadership in technology-enabled healthcare,” said Gaurav Dubey, Founder & CEO, Livlong. “Now with our Corporate Agency licensing, we are committed to delivering value-based personalized insurance solutions and healthcare solutions to both individuals and enterprises across India.” Livlong also launched an SME-focused vertical in early FY25 and has already partnered with over 450 enterprises in Tier–II markets, offering bundled health insurance and OPD services tailored to MSMEs. This move has opened up a new channel for customer acquisition, creating long-term value through B2B2C models while fulfilling a critical gap in India’s employer-led healthcare system in underserved markets.
As a vertically integrated platform operating at the intersection of healthtech and Insurtech. Livlong has stayed true to its value proposition of providing one-stop solution for affordable insurance cover & healthcare.
Livlong is also ramping up investments in elder care, including chronic care support and remote monitoring programs tailored for India’s ageing population.
“Our FY25 performance validates the strength of our multi-vertical strategy. We remain focused on building a scalable, tech-first health ecosystem that is inclusive, sustainable, and deeply rooted in value-based care,” Dubey added.
Livlong remains confident in achieving its target of doubling revenue by FY27, backed by multi-channel distribution, deeper market penetration, and product-led growth.
